Equities

Kopran Ltd

KOPRAN:NSI

Kopran Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)323.40
  • Today's Change-2.30 / -0.71%
  • Shares traded682.35k
  • 1 Year change+42.47%
  • Beta0.6999
Data delayed at least 15 minutes, as of Sep 20 2024 11:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue6,1465,5104,775
OPERATING EXPENSES
Cost of revenue total4,3303,8812,958
Selling, general and admin. expenses, total9741,005911
Depreciation/amortization129127111
Unusual expense(income)000
Other operating expenses, total344426
Total operating expense5,4665,0574,006
Operating income680453769
Other, net(15)(9.54)(3.12)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes675361818
Provision for income taxes16688207
Net income after taxes510272610
Minority interest------
Net income before extra. Items510272610
Total extraordinary items------
Net income510272610
Inc.avail. to common excl. extra. Items510272610
Inc.avail. to common incl. extra. Items510272610
EPS RECONCILIATION
Basic/primary weighted average shares484844
Basic/primary eps excl. extra items115.6514
Basic/primary eps incl. extra items115.6514
Dilution adjustment------
Diluted weighted average shares484844
Diluted eps excl. extra items115.6514
Diluted eps incl. extra items115.6514
COMMON STOCK DIVIDENDS
DPS - common stock primary issue3.003.003.00
Gross dividend - common stock145145145
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental644536
SUPPLEMENTAL INCOME
Depreciation, supplemental116120104
Total special items000
NORMALISED INCOME
Normalized income before taxes675361818
Effect of special items on income taxes000
Income tax excluding impact of special items16688207
Normalized income after tax510272610
Normalized income avail. to common510272610
Basic normalized EPS115.6514
Diluted normalized EPS115.6514
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.